glp 1 receptor agonists effects on cardiovascular risk reduction Frontiers Cardiovascular Protective Properties of GLP-1
Description
GLP-1s arent safe for everyone
So when Cigna decides its own employee health plan will stop covering GLP-1 weight-loss drugs such as Wegovy and Zepbound from July 1, the message travels beyond its workforce
Blurred vision: Changes to blood sugar can cause swelling of the lens of the eye, changing its overall shape and causing blurred vision
If such benefits are confirmed in randomized trials, GLP-1 medications could support mental health care in addition to roles in weight management and glycaemic control
